Abstract:Introduction: Left ventricular assist device (LVAD) implantation is a viable therapy for patients with severe end-stage heart failure, providing effective haemodynamic support and improved quality of life. The Heart Assist 5 (Micromed Cardiovascular Inc, Houston, TX) continuous-flow LVAD has been on the market in Europe since May 2009. Methods: We evaluated nine Heart Assist 5 LVAD patients with two- and three-dimensional transthoracic echocardiographic (TTE) and transoesophageal echocardiographic (TEE) parameters between December 2011 and December 2013. The pre-operative TTE LVAD evaluations included left ventricular (LV) function and structure, quantification of right ventricular (RV) function and tricuspid regurgitation (TR), assessment of aortic and mitral regurgitation, and presence of patent foramen ovale and intra-cardiac clots. Peri-operative TEE determined the inflow cannula and septum position, and assessed the de-airing process while weaning from cardiopulmonary bypass. Post-operative serial follow-up TTE showed the surgical results of LVAD implantation, determined the overall structure and function of the LV, RV and TR, and observed the inflow and outflow cannula position. Results: Nine patients who had undergone Heart Assist 5 LVAD implantation and had been followed up for more than 30 days were included in this study. Eight patients had ischaemic cardiomyopathy and one had adriamycin-induced cardiomyopathy. Pre-implantation data: the mean age of the patients was 52 ± 13 (34-64) years, mean body surface area (BSA) was 1.8 ± 0.2 (1.6-2.0) m2, mean cardiac index (CI) was 2.04 ± 0.4 (1.5-2.6) l/min/m2, mean cardiac output (CO) was 3.7 ± 0.7 (2.6-4.2) l/min, mean ejection fraction (EF) was 23 ± 5 (18-28)%, and right ventricular fractional area contraction (RVFAC) was 43 ± 9 (35-55)%. One patient had aortic valve replacement (AVR) during the LVAD implantation, and excess current alarms and increased power were suspected to be caused by a possible thrombus. Close follow up with TTE studies were carried out to clear the LV of thrombus formation, and the inflow cannula position was checked to maintain the septum in the midline, so preventing the suction cascade. Four patients were followed up for more than two years, and two were followed up for more than a year. Three patients died due to multi-organ failure. Follow-up speed-change TTE studies of six patients showed that the mean speed was 9 800 ± 600 (9 500-10 400) rpm, and mean CO was 4.7 ± 0.3 (4.3-5.0) l/min during the three-month post-implant period. Conclusion: We believe that TTE can play a major role in managing LVAD patients to achieve optimal settings for each patient. A large series is mandatory for assessment of echocardiographic studies on Heart Assist 5 LVAD.

Update on the Practical Role of Echocardiography in Selection, Implantation, and Management of Patients Requiring Left Ventricular Assist Device Therapy

Role of Echocardiography in the Evaluation of Left Ventricular Assist Devices: the Importance of Emerging Technologies

Role of echocardiography in the perioperative management of mechanical circulatory assistance

Role of Echocardiography in the Management of Patients with Advanced (Stage D) Heart Failure Related to Nonischemic Cardiomyopathy

Echocardiography and cardiac assist devices

Durable left ventricular assist devices: a contemporary review of their benefits and drawbacks

Echocardiographic imaging and ventricular mechanics in pulsatile-flow LVAD pediatric patients: a systematic approach

Left Ventricular Assist Device in Advanced Refractory Heart Failure: A Comprehensive Review of Patient Selection, Surgical Approaches, Complications and Future Perspectives

Left Ventricular Assist Device and the Kidney: Getting to the Heart of the Matter

Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices

Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography

Ventricular Arrhythmias in Left Ventricular Assist Device Patients—Current Diagnostic and Therapeutic Considerations

The role of palliative care for patients with left ventricular assist devices: a narrative review

Common Complications and Cardiopulmonary Resuscitation in Patients with Left Ventricular Assist Devices: A Narrative Review

Evolution of Mechanical Circulatory Support for advanced heart failure

The role of innovative modeling and imaging techniques in improving outcomes in patients with LVAD

Postoperative care of 14 patients with left ventricular assist devices: a case series

Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective?

Advanced Heart Failure: Therapeutic Options and Challenges in the Evolving Field of Left Ventricular Assist Devices

The use of left ventricular assist devices in the treatment of class IV heart failure patients: what the non-heart failure specialist needs to know

Intraoperative Echocardiography: Guide to Decision-Making